PFIZER LIMITED - United Kingdom 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:700-800
Total Number of Projects:400-500
2019
Criterium:Position:
Overall Score:400-500
Total Number of Projects:200-300
2018
Criterium:Position:
Overall Score:800-900
Total Number of Projects:300-400
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 38
As coordinator: 0
As participant: 38
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 34.601.665 0 2
2020 0 126.530.192 0 8
2019 0 177.439.080 0 11
2018 0 103.838.674 0 7
2017 0 66.023.667 0 8
2016 0 14.080.000 0 2

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA27
JANSSEN PHARMACEUTICA NV21
UCB BIOPHARMA16
ELI LILLY AND COMPANY LIMITED15
F HOFFMANNLA ROCHE15
BAYER13
SANOFIAVENTIS13
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT11
KATHOLIEKE UNIVERSITEIT LEUVEN11
NOVO NORDISK11
TAKEDA PHARMACEUTICALS INTERNATIONAL11
ABBVIE INC10
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG10
TAKEDA DEVELOPMENT CENTRE EUROPE10
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD9
UNIVERSITAIR MEDISCH CENTRUM UTRECHT9
UNIVERSITY OF NEWCASTLE UPON TYNE9
ASTRAZENECA8
CHARITE UNIVERSITAETSMEDIZIN BERLIN8
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN8
MERCK SHARP & DOHME CORP8
BAYER AKTIENGESELLSCHAFT7
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM7
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
MEDIZINISCHE UNIVERSITAET WIEN7
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT7
ACADEMISCH ZIEKENHUIS GRONINGEN6
KAROLINSKA INSTITUTE6
STICHTING KATHOLIEKE UNIVERSITEIT6
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL6
THE UNIVERSITY OF MANCHESTER6
UNIVERSITY OF CAMBRIDGE6
ASTRAZENECA AB5
FORUM DES PATIENTS EUROPEENS5
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
STICHTING VUMC5
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA5
THE UNIVERSITY OF LIVERPOOL5
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
EUROPEAN PATIENTS' FORUM4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER4
INSTITUT DE RECHERCHES SERVIER4
LEIDS UNIVERSITAIR MEDISCH CENTRUM4
SANOFIAVENTIS DEUTSCHLAND4
SERVICIO MADRILENO DE SALUD4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
UNIVERSITY COLLEGE LONDON4
UNIVERSITY OF BIRMINGHAM4
UNIVERSITY OF BOLOGNA4
UPPSALA UNIVERSITET4
VIB VZW4
ACADEMISCH ZIEKENHUIS LEIDEN3
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS3
ALLERGAN LIMITED3
AMGEN LIMITED3
ANTAROS MEDICAL AB3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
ASTELLAS PHARMA EUROPE BV3
BRISTOLMYERS SQUIBB COMPANY CORP3
CELGENE MANAGEMENT SARL3
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
EUROPEAN CANCER PATIENT COALITION3
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACIO SANT JOAN DE DEU3
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA3
GLAXOSMITHKLINE BIOLOGICALS3
GRUNENTHAL3
IXSCIENT LIMITED3
KING'S COLLEGE LONDON3
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE3
OSPEDALE PEDIATRICO BAMBINO GESU3
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU3
SERVICIO ANDALUZ DE SALUD3
STATENS LEGEMIDDELVERK3
STICHTING LYGATURE3
THE SYNERGIST3
THE UNIVERSITY OF EDINBURGH3
THE UNIVERSITY OF SHEFFIELD3
TTOPSTART BV3
UNIVERSITA VITASALUTE SAN RAFFAELE3
UNIVERSITAET ZUERICH3
UNIVERSITATSKLINIKUM ERLANGEN3
UNIVERSITEIT GENT3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF LEEDS3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
BAYER PHARMA2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
BIOMERIEUX2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
CONCENTRIS RESEARCH MANAGEMENT2
COVANCE LABORATORIES2

Constancy:

Total number of partners: 1106
Partner loyalty:
Frequent Partner: (> 2 projects): 530
Rare Partner: 576
Frequent / Rare Partner Ratio: 0.92

Project overview:

Start dateProjectacronymrolefundingpartners
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82545
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00039
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68723
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62539
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18637
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2020-01-01Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies ImmUniverseparticipant15.500.00026
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99827
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01WEB-RADR 2 WEB-RADR 2participant1.168.75011
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4participant7.370.00021
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023